查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855832

2025年全球封閉回路型神經調控處理器市場報告

Closed-Loop Neuromodulation Processor Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，封閉回路型神經調控處理器的市場規模迅速擴張，從2024年的22.2億美元成長到2025年的25.2億美元，複合年成長率達13.3%。這一成長與神經系統疾病盛行率的上升、疼痛管理治療需求的增加、人們對神經調控技術的認知不斷提高、其在癲癇治療中的應用日益廣泛以及在帕金森氏症管理中的使用不斷增加密切相關。

預計未來幾年，封閉回路型神經調控處理器市場規模將快速成長，2029年將達到41.1億美元，複合年成長率（CAGR）為13.0%。預測期內的成長主要受以下因素驅動：研發投入的增加、對個人化治療的日益偏好、對非侵入性治療需求的成長、在精神疾病領域應用範圍的擴大以及醫保政策的加強支持。預測期內的關鍵趨勢包括：人工智慧在反饋系統中的應用、小型化植入式設備的開發、無線通訊技術的進步以及雲端基礎的病患監測的應用。

封閉回路型神經調節處理器是醫療設備即時監測神經活動，並根據回饋自動調節電刺激，從而實現對神經系統功能的精確調節，並支持對神經系統疾病進行有效的、有針對性的治療。

封閉回路型調控處理器主要分為植入式和體外式兩種產品類型。植入式處理器是一種內建設備，可根據持續的生理回饋提供精確的神經刺激。這些處理器技術包括深部腦部刺激、脊髓刺激和迷走神經刺激。其主要應用領域包括慢性疼痛管理、癲癇、帕金森氏症、憂鬱症和其他神經系統疾病。這些設備主要用於醫院、專科診所、研究機構和其他醫療機構。

美國關稅的迅速上漲以及由此引發的貿易摩擦（始於2025年春季）對醫療設備行業產生了重大影響，尤其是進口診斷成像設備部件、手術用不銹鋼和塑膠耗材。醫院和診所抵制價格上漲，擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要重新認證設備，從而延緩產品上市時間。企業正透過關鍵零件的雙重採購、擴大國內同質化產品的生產以及加速研發經濟高效材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，提供封閉回路型神經調控處理器（CLP）市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、封閉回路型的市場細分、市場趨勢以及商機，為封閉回路型封閉回路型調控處理器行業的企業提供成功所需的關鍵數據。本封閉回路型神經調控處理器市場研究報告全面分析了該行業的現狀和未來發展趨勢，為您提供所需的一切觀點。

神經系統疾病盛行率的不斷上升預計將推動封閉回路型神經調控處理器市場的成長。神經病變是指損害神經系統功能的疾病，影響大腦、脊髓和周邊神經，並可能導致運動、認知和感覺方面的障礙。神經病變的增加主要是由於全球人口老化，導致阿茲海默症和帕金森氏症等疾病的發生率上升。閉合迴路神經調控處理器透過持續追蹤大腦活動並即時提供靶向電刺激來調節異常的神經模式，從而幫助控制這些疾病。例如，根據美國健康指標與評估研究所（IHME）預測，到2022年，全球將有43%的人口患有神經系統疾病，預計到2050年這一數字將翻倍。這種日益嚴重的疾病負擔正在推動封閉回路型調控處理器市場的擴張。

封閉回路型調控處理器市場的公司正在整合腦機介面技術，以提高治療精確度、增強症狀控制，並為每位神經系統疾病患者量身訂做治療方案，從而拓展個人化治療選擇。腦機介面是一種系統，它透過檢測、解讀神經活動並將其轉化為可執行的指令，促進大腦與外部設備之間的直接互動。這些介面通常整合到神經調控和復健設備中，能夠根據患者的腦波訊號進行即時監測和自適應刺激。例如，2025年2月，總部位於美國的醫療技術公司Medtronic)的BrainSense自適應深部腦刺激裝置和BrainSense電極識別裝置獲得了美國食品藥物管理局( FDA)的核准。這標誌著迄今為止腦機介面技術規模最大的商業性應用。該系統持續監測腦部活動，並自動調整刺激，從而為帕金森氏症患者提供個人化治療。臨床研究表明，與傳統的深部腦部刺激相比，該系統能夠更好地控制症狀、減少運動波動並改善患者預後。

2023年9月，總部位於英國的生物技術研究公司Amber Therapeutics收購了Bioinduction，收購金額未揭露。此次收購旨在透過整合Bioinduction的微型顱神經神經刺激設備－Picostim DyNeuMo系統，增強Amber Therapeutics在閉合迴路神經調控領域的地位。 Bioinduction Limited是一家總部位於英國的醫療設備製造商，專注於封閉回路型神經調控技術。

封閉回路型調控處理器市場由提供自適應神經刺激程式設計、即時監測和臨床支援等服務的營業單位所獲得的收入所構成。市場價值還包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。封閉回路型神經調控處理器市場還包括植入式神經刺激設備、感測處理器和連接軟體平台的銷售。此市場價值為“出廠價”，即製造商或生產商銷售的商品價值，無論銷售對像是其他營業單位（包括下游製造商、批發商、經銷商和零售商）還是直接銷售給最終客戶。該價值還包括製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球封閉回路型神經調控處理器：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 終端用戶產業分析
  • 全球封閉回路型神經調控處理器市場：成長率分析
  • 全球封閉回路型神經調控處理器市場表現：規模與成長，2019-2024年
  • 全球封閉回路型神經調控處理器市場預測：規模與成長，2024-2029年，2034年預測
  • 全球封閉回路型神經調控處理器：總潛在市場規模 (TAM)

第6章 市場細分

  • 全球封閉回路型神經調控處理器市場：依產品類型分類，實際值及預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 嵌入式處理器
  • 外部處理器
  • 全球封閉回路型神經調控處理器市場：依技術分類，實際值及預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 深部腦部刺激
  • 脊髓刺激
  • 迷走神經刺激
  • 其他技術
  • 全球封閉回路型神經調控處理器市場：依應用領域分類，實際結果及預測，2019-2024年、2024-2029年預測、2034年預測
  • 慢性疼痛管理
  • 癲癇
  • 帕金森氏症
  • 憂鬱症
  • 其他用途
  • 全球封閉回路型神經調控處理器市場：依最終用戶分類，實際數據及預測數據，2019-2024年、2024-2029年預測數據、2034年預測數據
  • 醫院
  • 專科診所
  • 研究所
  • 其他最終用戶
  • 全球封閉回路型神經調控處理器市場：嵌入式處理器細分市場：按類型分類，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 深部腦部刺激（DBS）處理器
  • 脊髓刺激（SCS）處理器
  • 迷走神經刺激（VNS）處理器
  • 薦椎神經刺激（SNS）處理器
  • 周邊神經刺激（PNS）處理器
  • 全球封閉回路型神經調控處理器市場：體外處理器細分：按類型分類，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 穿戴式神經調節控制器
  • 手持式程式設計設備
  • 外部脈衝發生器
  • 充電系統和電源管理
  • 無線通訊介面

第7章 區域和國家分析

  • 全球封閉回路型神經調控處理器市場：區域分析、預測（2019-2024年、2024-2029年預測、2034年預測）
  • 全球封閉回路型神經調控處理器市場：國家、實際結果與預測，2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 封閉回路型神經調控處理器市場：競爭格局
  • 封閉回路型神經調控處理器市場：公司概況
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Integer Holdings Overview, Products and Services, Strategy and Financial Analysis
    • Beijing PINS Medical Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • CorTec
  • NeuroPace
  • Saluda Medical
  • NeuSpera Medical
  • Inbrain Neuroelectronics
  • Blackrock Neurotech
  • Soterix Medical（some adaptive neuromodulate devices）
  • Great Lakes NeuroTechnologies
  • SensArs Neuroprosthetics
  • Biotronik SE & Co. KG
  • BioControl Medical
  • Precision Neuroscience
  • Motif Neurotech
  • Synergia Medical
  • BrainQ Technologies

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年封閉回路型神經調控處理器市場：提供新機會的國家
  • 2029年封閉回路型神經調控處理器市場：充滿新機會的細分市場
  • 2029年封閉回路型神經調控處理器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38481

A closed-loop neuromodulation processor is a medical device that monitors neural activity in real time and automatically adjusts electrical stimulation based on feedback. It enables precise regulation of nervous system function, supporting effective and targeted treatment of neurological disorders.

The primary product types of closed-loop neuromodulation processors include implantable processors and external processors. Implantable processors are internal devices that deliver precise neural stimulation based on continuous physiological feedback. Technologies in these processors include deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, and others. Key application areas encompass chronic pain management, epilepsy, Parkinson's disease, depression, and other neurological conditions. These devices are primarily used in hospitals, specialty clinics, research institutes, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The closed-loop neuromodulation processor market research report is one of a series of new reports from The Business Research Company that provides closed-loop neuromodulation processor market statistics, including the closed-loop neuromodulation processor industry global market size, regional shares, competitors with the closed-loop neuromodulation processor market share, detailed closed-loop neuromodulation processor market segments, market trends, and opportunities, and any further data you may need to thrive in the closed-loop neuromodulation processor industry. This closed-loop neuromodulation processor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The closed-loop neuromodulation processor market size has grown rapidly in recent years. It will grow from $2.22 billion in 2024 to $2.52 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth during the historic period is linked to the increasing prevalence of neurological disorders, rising demand for pain management therapies, growing awareness of neuromodulation techniques, expanding adoption in epilepsy treatment, and higher usage in Parkinson's disease management.

The closed-loop neuromodulation processor market size is expected to see rapid growth in the next few years. It will grow to $4.11 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth projected for the forecast period is driven by increasing investments in research and development activities, growing preference for personalized treatments, rising demand for non-invasive therapies, expanding use in mental health disorders, and stronger support from reimbursement policies. Primary trends during the forecast period include integration of AI in feedback systems, development of miniaturized implantable devices, advancements in wireless communication technologies, and implementation of cloud-based patient monitoring.

The increasing prevalence of neurological disorders is expected to support the growth of the closed-loop neuromodulation processor market. A neurological disorder is a condition that disrupts the function of the nervous system, affecting the brain, spinal cord, or peripheral nerves, and can result in challenges related to movement, cognition, or sensation. The rise in neurological disorders is largely attributed to an aging global population, which has led to a higher incidence of conditions such as Alzheimer's disease and Parkinson's disease. Closed-loop neuromodulation processors assist in managing these conditions by continuously tracking brain activity and delivering targeted electrical stimulation in real time to regulate abnormal neural patterns. For example, according to the Institute for Health Metrics and Evaluation, a research organization based in the United States, neurological conditions impacted 43 percent of the global population in 2022, with projections suggesting this figure could double by the year 2050. This growing burden is contributing to the expansion of the closed-loop neuromodulation processor market.

Companies operating in the closed-loop neuromodulation processor market are advancing personalized treatment options by integrating brain-computer interface technology to improve therapeutic precision, enhance symptom control, and tailor care to individual patients with neurological disorders. A brain-computer interface is a system that facilitates direct interaction between the brain and an external device by detecting, interpreting, and converting neural activity into actionable commands. These interfaces are often embedded in neuromodulation or rehabilitation devices, allowing real-time monitoring and adaptive stimulation based on a patient's brain signals. For instance, in February 2025, Medtronic plc, a medical technology company based in the United States, received approval from the United States Food and Drug Administration for its BrainSense Adaptive Deep Brain Stimulation and BrainSense Electrode Identifier. This represented the largest commercial deployment of brain-computer interface technology to date. The system continuously monitors brain activity and adjusts stimulation automatically, personalizing therapy for individuals with Parkinson's disease. Clinical studies showed improved symptom management, reduced motor fluctuations, and better patient outcomes when compared to traditional deep brain stimulation methods.

In September 2023, Amber Therapeutics Ltd., a biotechnology research company based in the United Kingdom, acquired Bioinduction Limited for an undisclosed amount. The goal of this acquisition was to strengthen Amber Therapeutics' presence in the closed-loop neuromodulation space by incorporating Bioinduction's Picostim DyNeuMo system, a compact cranial neurostimulator. Bioinduction Limited is a medical equipment manufacturer based in the United Kingdom, specializing in closed-loop neuromodulation technologies.

Major players in the closed-loop neuromodulation processor market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Integer Holdings, Beijing PINS Medical, CorTec, NeuroPace, Saluda Medical, NeuSpera Medical, Inbrain Neuroelectronics, Blackrock Neurotech, Soterix Medical (some adaptive neuromodulate devices), Great Lakes NeuroTechnologies, SensArs Neuroprosthetics, Biotronik SE & Co. KG, BioControl Medical, Precision Neuroscience, Motif Neurotech, Synergia Medical, BrainQ Technologies.

North America was the largest region in the closed-loop neuromodulation processor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in closed-loop neuromodulation processor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the closed-loop neuromodulation processor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The closed-loop neuromodulation processor market consists of revenues earned by entities by providing services such as adaptive neurostimulation programming, real-time monitoring, and clinical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The closed-loop neuromodulation processor market also includes sales of implantable neuromodulation devices, sensing-enabled processors, and connected software platforms. Values in this market are 'factory gate' values the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value also includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Closed-Loop Neuromodulation Processor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on closed-loop neuromodulation processor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for closed-loop neuromodulation processor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The closed-loop neuromodulation processor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Implantable Processors; External Processors
  • 2) By Technology: Deep Brain Stimulation; Spinal Cord Stimulation; Vagus Nerve Stimulation; Other Technologies
  • 3) By Application: Chronic Pain Management; Epilepsy; Parkinson's Disease; Depression; Other Applications
  • 4) By End-User: Hospitals; Specialty Clinics; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Implantable Processors: Deep Brain Stimulation (DBS) Processors; Spinal Cord Stimulation (SCS) Processors; Vagus Nerve Stimulation (VNS) Processors; Sacral Nerve Stimulation (SNS) Processors; Peripheral Nerve Stimulation (PNS) Processors
  • 2) By External Processors: Wearable Neuromodulation Controllers; Handheld Programming Devices; External Pulse Generators; Charging Systems And Power Management Units; Wireless Communication Interfaces
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Integer Holdings; Beijing PINS Medical; CorTec; NeuroPace; Saluda Medical; NeuSpera Medical; Inbrain Neuroelectronics; Blackrock Neurotech; Soterix Medical (some adaptive neuromodulate devices); Great Lakes NeuroTechnologies; SensArs Neuroprosthetics; Biotronik SE & Co. KG; BioControl Medical; Precision Neuroscience; Motif Neurotech; Synergia Medical; BrainQ Technologies
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Closed-Loop Neuromodulation Processor Market Characteristics

3. Closed-Loop Neuromodulation Processor Market Trends And Strategies

4. Closed-Loop Neuromodulation Processor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Closed-Loop Neuromodulation Processor Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Closed-Loop Neuromodulation Processor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Closed-Loop Neuromodulation Processor Market Growth Rate Analysis
  • 5.4. Global Closed-Loop Neuromodulation Processor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Closed-Loop Neuromodulation Processor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Closed-Loop Neuromodulation Processor Total Addressable Market (TAM)

6. Closed-Loop Neuromodulation Processor Market Segmentation

  • 6.1. Global Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Processors
  • External Processors
  • 6.2. Global Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deep Brain Stimulation
  • Spinal Cord Stimulation
  • Vagus Nerve Stimulation
  • Other Technologies
  • 6.3. Global Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chronic Pain Management
  • Epilepsy
  • Parkinson's Disease
  • Depression
  • Other Applications
  • 6.4. Global Closed-Loop Neuromodulation Processor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Research Institutes
  • Other End Users
  • 6.5. Global Closed-Loop Neuromodulation Processor Market, Sub-Segmentation Of Implantable Processors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deep Brain Stimulation (DBS) Processors
  • Spinal Cord Stimulation (SCS) Processors
  • Vagus Nerve Stimulation (VNS) Processors
  • Sacral Nerve Stimulation (SNS) Processors
  • Peripheral Nerve Stimulation (PNS) Processors
  • 6.6. Global Closed-Loop Neuromodulation Processor Market, Sub-Segmentation Of External Processors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable Neuromodulation Controllers
  • Handheld Programming Devices
  • External Pulse Generators
  • Charging Systems And Power Management
  • Wireless Communication Interfaces

7. Closed-Loop Neuromodulation Processor Market Regional And Country Analysis

  • 7.1. Global Closed-Loop Neuromodulation Processor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Closed-Loop Neuromodulation Processor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Closed-Loop Neuromodulation Processor Market

  • 8.1. Asia-Pacific Closed-Loop Neuromodulation Processor Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Closed-Loop Neuromodulation Processor Market

  • 9.1. China Closed-Loop Neuromodulation Processor Market Overview
  • 9.2. China Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Closed-Loop Neuromodulation Processor Market

  • 10.1. India Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Closed-Loop Neuromodulation Processor Market

  • 11.1. Japan Closed-Loop Neuromodulation Processor Market Overview
  • 11.2. Japan Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Closed-Loop Neuromodulation Processor Market

  • 12.1. Australia Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Closed-Loop Neuromodulation Processor Market

  • 13.1. Indonesia Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Closed-Loop Neuromodulation Processor Market

  • 14.1. South Korea Closed-Loop Neuromodulation Processor Market Overview
  • 14.2. South Korea Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Closed-Loop Neuromodulation Processor Market

  • 15.1. Western Europe Closed-Loop Neuromodulation Processor Market Overview
  • 15.2. Western Europe Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Closed-Loop Neuromodulation Processor Market

  • 16.1. UK Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Closed-Loop Neuromodulation Processor Market

  • 17.1. Germany Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Closed-Loop Neuromodulation Processor Market

  • 18.1. France Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Closed-Loop Neuromodulation Processor Market

  • 19.1. Italy Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Closed-Loop Neuromodulation Processor Market

  • 20.1. Spain Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Closed-Loop Neuromodulation Processor Market

  • 21.1. Eastern Europe Closed-Loop Neuromodulation Processor Market Overview
  • 21.2. Eastern Europe Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Closed-Loop Neuromodulation Processor Market

  • 22.1. Russia Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Closed-Loop Neuromodulation Processor Market

  • 23.1. North America Closed-Loop Neuromodulation Processor Market Overview
  • 23.2. North America Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Closed-Loop Neuromodulation Processor Market

  • 24.1. USA Closed-Loop Neuromodulation Processor Market Overview
  • 24.2. USA Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Closed-Loop Neuromodulation Processor Market

  • 25.1. Canada Closed-Loop Neuromodulation Processor Market Overview
  • 25.2. Canada Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Closed-Loop Neuromodulation Processor Market

  • 26.1. South America Closed-Loop Neuromodulation Processor Market Overview
  • 26.2. South America Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Closed-Loop Neuromodulation Processor Market

  • 27.1. Brazil Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Closed-Loop Neuromodulation Processor Market

  • 28.1. Middle East Closed-Loop Neuromodulation Processor Market Overview
  • 28.2. Middle East Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Closed-Loop Neuromodulation Processor Market

  • 29.1. Africa Closed-Loop Neuromodulation Processor Market Overview
  • 29.2. Africa Closed-Loop Neuromodulation Processor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Closed-Loop Neuromodulation Processor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Closed-Loop Neuromodulation Processor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Closed-Loop Neuromodulation Processor Market Competitive Landscape And Company Profiles

  • 30.1. Closed-Loop Neuromodulation Processor Market Competitive Landscape
  • 30.2. Closed-Loop Neuromodulation Processor Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Integer Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Beijing PINS Medical Overview, Products and Services, Strategy and Financial Analysis

31. Closed-Loop Neuromodulation Processor Market Other Major And Innovative Companies

  • 31.1. CorTec
  • 31.2. NeuroPace
  • 31.3. Saluda Medical
  • 31.4. NeuSpera Medical
  • 31.5. Inbrain Neuroelectronics
  • 31.6. Blackrock Neurotech
  • 31.7. Soterix Medical (some adaptive neuromodulate devices)
  • 31.8. Great Lakes NeuroTechnologies
  • 31.9. SensArs Neuroprosthetics
  • 31.10. Biotronik SE & Co. KG
  • 31.11. BioControl Medical
  • 31.12. Precision Neuroscience
  • 31.13. Motif Neurotech
  • 31.14. Synergia Medical
  • 31.15. BrainQ Technologies

32. Global Closed-Loop Neuromodulation Processor Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Closed-Loop Neuromodulation Processor Market

34. Recent Developments In The Closed-Loop Neuromodulation Processor Market

35. Closed-Loop Neuromodulation Processor Market High Potential Countries, Segments and Strategies

  • 35.1 Closed-Loop Neuromodulation Processor Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Closed-Loop Neuromodulation Processor Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Closed-Loop Neuromodulation Processor Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer